Edwards Lifesciences Corporation (EW) vs Medline Inc. (MDLN)

MDLN leads on 6 of 11 compared metrics.

A side-by-side comparison of Edwards Lifesciences Corporation and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 28, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Compare

Total return — EW vs MDLN

growth of $100 · last 1y
EW +6.4%MDLN -5.2%EW compounded faster
8090100110120Start $1002026$106$95
EW MDLN

EW vs MDLN: by the numbers

  • EW is the larger company ($52.27B vs $32.87B market cap).
  • MDLN trades at the lower earnings multiple (32.12 vs 48.29 P/E).
  • EW converts more revenue to profit (17.34% vs 3.31% net margin).

Which is better, EW or MDLN?

Metric tally: EW 5 · MDLN 6

It depends on what you're optimizing for:

ValueMDLN(lower P/E)
QualityEW(higher ROIC)

Metrics side by side

Valuation

MetricEWMDLN
P/E ratio48.2932.12
Forward P/E26.8923.45
P/S ratio8.361.10
P/B ratio5.102.84
PEG ratio7.03
EV / EBITDA26.8014.24
FCF yield2.07%4.76%

Profitability

MetricEWMDLN
Gross margin78.01%24.04%
Operating margin27.62%7.04%
Net margin17.34%3.31%
ROE10.58%8.55%
ROIC11.40%5.69%

Growth (annualized)

MetricEWMDLN
Revenue CAGR (5Y)7.10%
EPS CAGR (5Y)6.87%
FCF CAGR (5Y)8.74%
Total return CAGR (5Y)-2.60%

Frequently asked

Which is better, EW or MDLN?
It depends on your goal. value: MDLN (lower P/E); quality: EW (higher ROIC). Across all compared metrics, MDLN leads 6 to 5.
Is EW or MDLN cheaper?
On trailing earnings, MDLN is cheaper: EW trades at a 48.29 P/E and MDLN at 32.12.
Is EW or MDLN more profitable?
EW runs the higher net margin — EW at 17.34% versus MDLN at 3.31%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 28, 2026.